Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001

Clinical trial NCT01494922 · COMPLETED

Trial details

NCT number: NCT01494922
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Reduction in Severity of Skin Scarring

Start date: 2011-12-08
Primary completion: 2013-09-10
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.